Your browser doesn't support javascript.
loading
Exploring Genetic Testing for Rare Disorders of Obesity: Experience and Perspectives of Pediatric Weight Management Providers.
Roberts, Karyn J; Chaves, Eileen; Ariza, Adolfo J; Thaker, Vidhu V; Cho, Chi C; Binns, Helen J.
Afiliação
  • Roberts KJ; School of Nursing, College of Health Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
  • Chaves E; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Ariza AJ; Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Thaker VV; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Cho CC; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
  • Binns HJ; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USA.
Child Obes ; 2024 Jan 08.
Article em En | MEDLINE | ID: mdl-38227789
ABSTRACT

Background:

This study describes experiences and perspectives of pediatric weight management (PWM) providers on the implementation of genetic testing for rare causes of obesity.

Methods:

Purposive and snowball sampling recruited PWM providers via email to complete a 23-question survey with multiple choice and open-ended questions. Analyses include descriptive statistics, Fisher's exact test, one-way ANOVA with Tukey's post hoc test, and qualitative analysis.

Results:

Of the 55 respondents, 80% reported ordering genetic testing. Respondents were primarily physicians (82.8%) in practice for 11-20 years (42%), identified as female (80%), White (76.4%), and non-Hispanic (92.7%) and provided PWM care 1-4 half day sessions per week. Frequently reported patient characteristics that prompted testing did not vary by provider years of experience (YOE). These included obesity onset before age 6, hyperphagia, dysmorphic facies, and developmental delays. The number of patient characteristics that prompted testing varied by YOE (p = 0.03); respondents with 6-10 YOE indicated more patient characteristics than respondents with >20 YOE (mean 10.3 vs. mean 6.2). The reported primary benefit of testing was health information for patients/families; the primary drawback was the high number of indeterminate tests. Ethical concerns expressed were fear of increasing weight stigma, discrimination, and impact on insurance coverage. Respondents (42%) desired training and guidance on interpreting results and counseling patients and families.

Conclusions:

Most PWM providers reported genetic testing as an option for patient management. Provider training in genetics/genomics and research into provider and family attitudes on the genetics of obesity and the value of genetic testing are next steps to consider.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Idioma: En Ano de publicação: 2024 Tipo de documento: Article